Imagine trying to repair a microscopic circuit board while looking through a tiny keyhole with shaky hands. This technology acts like a smart GPS and steady-hand assistant for eye surgeons. It uses AI to map the eye's surface in real-time, guiding the tools safely to prevent accidental damage to the delicate retina.
Retina surgery is extremely difficult due to the delicate nature of the eye and limited visibility, requiring years of training to avoid surgical trauma.
A GEYEDANCE Clinical Solution integrating a Common-Path OCT scanning system with the Preceyes Surgical System, including an AI-based measurement tool for retinal geometry.
If you are a robotics firm dealing with the extreme precision requirements of ocular surgery — this project developed an AI-based guidance system that integrates with the Preceyes Surgical System to increase reproducibility and safety margins.
If you are an imaging company dealing with limited measurement depth during live surgery — this project developed a Common-Path OCT system for fiber-based in vivo scanning that provides real-time retinal geometry.
If you are a clinic dealing with the high training burden and risk of surgical trauma in retina procedures — this project developed a clinical solution that reduces the mental and physical load on surgeons.
Based on available project data, specific pricing or cost details are not provided.
The project involves industrial partners like Carl Zeiss AG and Carl Zeiss Meditec AG, suggesting a path toward industrial scale and certification.
Based on available project data, specific licensing terms are not mentioned, though the project aims for successful exploitation of the solution.
The system is specifically integrated with the CE certified Preceyes Surgical System (PPS) to create a validated clinical solution.
The project period runs from 2022-09-01 to 2025-08-31, aiming for a TRL of 7 or higher by the end of the term.
The consortium is highly balanced for commercialization, featuring a 43% industry ratio with 3 industrial partners, including global leaders Carl Zeiss AG and Carl Zeiss Meditec AG. With 2 SMEs and 3 universities across 5 countries, the group combines academic AI expertise from Verona and Bern with certified hardware from Preceyes and clinical validation from the University of Ferrara.
Contact ACMIT GMBH in Austria
Request technical specifications for the Common-Path OCT integration.
